Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Standard

Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study. / Sylow, Lykke; Grand, Mia Klinten; von Heymann, Annika; Persson, Frederik; Siersma, Volkert; Kriegbaum, Margit; Lykkegaard Andersen, Christen; Johansen, Christoffer.

I: Diabetes Care, Bind 45, Nr. 6, 2022, s. e105-e106.

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Harvard

Sylow, L, Grand, MK, von Heymann, A, Persson, F, Siersma, V, Kriegbaum, M, Lykkegaard Andersen, C & Johansen, C 2022, 'Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study', Diabetes Care, bind 45, nr. 6, s. e105-e106. https://doi.org/10.2337/dc22-0232

APA

Sylow, L., Grand, M. K., von Heymann, A., Persson, F., Siersma, V., Kriegbaum, M., Lykkegaard Andersen, C., & Johansen, C. (2022). Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study. Diabetes Care, 45(6), e105-e106. https://doi.org/10.2337/dc22-0232

Vancouver

Sylow L, Grand MK, von Heymann A, Persson F, Siersma V, Kriegbaum M o.a. Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study. Diabetes Care. 2022;45(6):e105-e106. https://doi.org/10.2337/dc22-0232

Author

Sylow, Lykke ; Grand, Mia Klinten ; von Heymann, Annika ; Persson, Frederik ; Siersma, Volkert ; Kriegbaum, Margit ; Lykkegaard Andersen, Christen ; Johansen, Christoffer. / Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study. I: Diabetes Care. 2022 ; Bind 45, Nr. 6. s. e105-e106.

Bibtex

@article{4fa60bfaafd8466c8aa8ed08ed8005bf,
title = "Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study",
abstract = "For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.",
author = "Lykke Sylow and Grand, {Mia Klinten} and {von Heymann}, Annika and Frederik Persson and Volkert Siersma and Margit Kriegbaum and {Lykkegaard Andersen}, Christen and Christoffer Johansen",
note = "CURIS 2022 NEXS 144",
year = "2022",
doi = "10.2337/dc22-0232",
language = "English",
volume = "45",
pages = "e105--e106",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association",
number = "6",

}

RIS

TY - JOUR

T1 - Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

AU - Sylow, Lykke

AU - Grand, Mia Klinten

AU - von Heymann, Annika

AU - Persson, Frederik

AU - Siersma, Volkert

AU - Kriegbaum, Margit

AU - Lykkegaard Andersen, Christen

AU - Johansen, Christoffer

N1 - CURIS 2022 NEXS 144

PY - 2022

Y1 - 2022

N2 - For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.

AB - For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.

U2 - 10.2337/dc22-0232

DO - 10.2337/dc22-0232

M3 - Letter

C2 - 35653597

VL - 45

SP - e105-e106

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 6

ER -

ID: 308553167